Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

We’re using it for fatty liver [disease], high cholesterol, you name it.” Ozempic, Mounjaro, Wegovy, Victoza and Trulicity ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

If you plan to become pregnant in the near future, your provider may switch you to a different GLP-1 such as liraglutide (Saxenda or Victoza). You take liraglutide daily, vs. weekly for Ozempic ...

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

The researchers analysed 4,000 obese participants aged 12 to 19 on semaglutide, the drug in Ozempic and Wegovy, or liraglutide, sold as Victoza and Saxenda. Their health data was them compared to ...

Some GLP-1s, like Ozempic (semaglutide), tirzepatide (Mounjaro), and dulaglutide (Trulicity), are usually taken weekly. Others, like liraglutide (Saxenda, Victoza), are typically administered daily.

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...